http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019160306-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f402d1f8d42afe235f91a1b5c57b8c47 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_738359369a31266b4a6dfd247e4069f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbcfab2956488fc354e33050fd903369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe5c7a0c20c7e175bef04d739bce8cef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853549c888d072785a54d36f0d112b19 |
publicationDate | 2019-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2019160306-A1 |
titleOfInvention | Drug delivery implant for treating eye diseases, and preparation method therefor |
abstract | The present invention provides a sustained-release implant for treating eye diseases, having a predetermined size of a three-dimensional shape since albumin nanoparticles containing a drug for treating eye diseases are freeze-dried, compressed and coated. The implant of the present invention can have a predetermined mechanical strength since a nanoparticle powder is compressed, and can also gradually decompose, because of the characteristic surface of a frozen and compressed structure, from the surface to the center thereof. In addition, since the implant of the present invention is coated with a polymer, the mechanical strength of the implant can be further improved, and since a coated polymer material is first decomposed even if the implant is located within the eyeball for a long time, the decomposition of the albumin nanoparticles and a drug release speed can be delayed. Additionally, albumin molecules are gradually released and delivered to ocular tissue and, particularly, to the retina by the decomposition of the nanoparticles in the implant of the present invention, and thus effects (of albumin molecules themselves) such as the protection of nervous tissue and the delay of the death thereof can also be expected. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114159412-A |
priorityDate | 2018-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.